Multidrug resistant clones of Salmonella Infantis of broiler origin in Europe

International Journal of Food Microbiology
Noémi NógrádyBéla Nagy

Abstract

The aim of the study was to investigate the potential spread of the previously described multidrug-resistant (MDR) Hungarian clone of Salmonella Infantis of broiler origin in Europe. Therefore, 76 strains isolated between 2004 and 2009 from raw meat and fecal samples of broiler origin in nine European countries - including Hungary - were examined by phage typing, antimicrobial resistance typing, pulsed-field gel electrophoresis (PFGE) profile and plasmid analysis. The strains could be divided into two large PFGE clusters with 92% similarity. Cluster A (n=39) contained 15 German, seven Italian, five British, five Polish isolates, one Austrian and one Hungarian isolate. Five Hungarian isolates that were isolated prior to the appearance of the MDR clone also belonged to this cluster. Strains of this cluster comprised seven pulsotypes and 14 different phage types and were mostly susceptible to the 12 antimicrobials tested. Cluster B (n=33) contained all but one of the recent Austrian (n=14) and of Hungarian (n=9), six Polish, one Italian and one German as well as the single Turkish and the Romanian strains, representing five pulsotypes. The strains of this cluster were mostly PT213, with MDR (nalidixic acid-streptomycin-sulphomamid...Continue Reading

References

Jan 1, 1995·Antimicrobial Agents and Chemotherapy·C LévesqueP H Roy
May 25, 2006·The Journal of Antimicrobial Chemotherapy·Corinna KehrenbergStefan Schwarz
Sep 5, 2006·International Journal of Antimicrobial Agents·Francis ShahadaKozo Takase
Jul 10, 2007·The Journal of Antimicrobial Chemotherapy·Noémi NógrádyBéla Nagy
Oct 30, 2010·Emerging Infectious Diseases·Ohad Gal-MorIsrael Nissan
Aug 13, 2011·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Ama SzmolkaBéla Nagy

❮ Previous
Next ❯

Citations

Dec 29, 2015·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·Patrícia AntunesLuísa Peixe
Dec 9, 2014·Environmental Pollution·J Brett SallachShannon Bartelt-Hunt
Jun 27, 2013·The Journal of Antimicrobial Chemotherapy·Divya Prakash GnanadhasDipshikha Chakravortty
Jul 19, 2013·Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases·Fernanda AlmeidaJuliana Pfrimer Falcão
Jul 8, 2014·Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases·Eiji YokoyamaSatoshi Murakami
Jan 27, 2015·Foodborne Pathogens and Disease·Marjorie E Doyle
Apr 23, 2020·Frontiers in Microbiology·Tibor NagyFerenc Olasz
Feb 19, 2019·EFSA Journal·UNKNOWN EFSA Panel on Biological Hazards (EFSA BIOHAZ Panel)Robert Davies
Sep 3, 2020·EFSA Journal·UNKNOWN European Food Safety Authority, UNKNOWN European Centre for Disease Prevention and Control
Apr 4, 2021·International Journal of Food Microbiology·Trond MøretrøSolveig Langsrud
Apr 20, 2021·EFSA Journal·UNKNOWN European Food Safety Authority, UNKNOWN European Centre for Disease Prevention and Control
Sep 25, 2021·International Microbiology : the Official Journal of the Spanish Society for Microbiology·Sahin Namli, Yesim Soyer

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Bacteriophage: Phage Therapy

Phage therapy uses bacterial viruses (bacteriophages) to treat bacterial infections and is widely being recognized as an alternative to antibiotics. Here is the latest research.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.